Ascentage Pharma Group International (FRA:36X)
0.8450
-5.3050 (-86.26%)
At close: Dec 18, 2025
FRA:36X Market Cap
FRA:36X has a market cap or net worth of €2.2 billion as of December 22, 2025. Its market cap has increased by 33.76% in one year.
Market Cap
2.20B
Enterprise Value
2.21B
Revenue
46.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.85
Market Cap Chart
Since October 28, 2019, FRA:36X's market cap has increased from 872.23M to 2.20B, an increase of 152.63%. That is a compound annual growth rate of 16.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 2.27B | 29.97% |
| Dec 31, 2024 | 1.75B | 94.52% |
| Dec 29, 2023 | 899.54M | 13.02% |
| Dec 30, 2022 | 795.88M | -2.84% |
| Dec 31, 2021 | 819.17M | -8.59% |
| Dec 31, 2020 | 896.18M | 28.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 129.76B |
| Siemens Energy AG | 102.77B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Rheinmetall AG | 71.12B |
| Deutsche Bank Aktiengesellschaft | 62.30B |